These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 861135)

  • 1. The comparability of dosage regimens of Lanoxin tablets and Lanoxicaps.
    Johnson BF; Smith G; French J
    Br J Clin Pharmacol; 1977 Apr; 4(2):209-11. PubMed ID: 861135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of steady-state serum concentrations of digoxin in tablets (Lanoxin) and capsules (Lanoxicaps) in the elderly.
    Pouwels MJ; Hooymans PM; van der Aa GC; Gribnau FW
    DICP; 1991 Oct; 25(10):1043-6. PubMed ID: 1803786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The comparative bioavailability of Lanoxin tablets and Lanoxicaps with and without sorbitol.
    O'Grady J; Johnson BF; Bye C; French J
    Eur J Clin Pharmacol; 1978 Dec; 14(5):357-60. PubMed ID: 729628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A completely absorbed oral preparation of digoxin.
    Johnson BF; Bye C; Jones G; Sabey GA
    Clin Pharmacol Ther; 1976 Jun; 19(6):746-51. PubMed ID: 1269214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological availability of digoxin from Lanoxin produced in the United Kingdom.
    Johnson BF; Fowle AS; Lader S; Fox J; Munro-Faure AD
    Br Med J; 1973 Nov; 4(5888):323-6. PubMed ID: 4758424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radioimmunoassay for digoxin in human urine.
    Marwaha RK; Johnson BF
    J Clin Chem Clin Biochem; 1984 Jun; 22(6):403-6. PubMed ID: 6481305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of high-dose cancer chemotherapy on the absorption of digoxin in two different formulations.
    Bjornsson TD; Huang AT; Roth P; Jacob DS; Christenson R
    Clin Pharmacol Ther; 1986 Jan; 39(1):25-8. PubMed ID: 3943266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of digoxin from tablets and capsules in subjects with malabsorption syndromes.
    Heizer WD; Pittman AW; Hammond JE; Fitch DD; Bustrack JA; Hull JH
    DICP; 1989 Oct; 23(10):764-9. PubMed ID: 2815851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption of digoxin from a new microencapsulated formulation.
    Bergdahl B; Bogentoft C; Jonsson UE; Magnusson JO
    Eur J Clin Pharmacol; 1980 Jun; 17(6):443-7. PubMed ID: 7398735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A steady-state evaluation of the effects of propantheline bromide and cholestyramine on the bioavailability of digoxin when administered as tablets or capsules.
    Brown DD; Schmid J; Long RA; Hull JH
    J Clin Pharmacol; 1985; 25(5):360-4. PubMed ID: 4031112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from Lanoxin capsules to Lanoxin tablets in the debilitated elderly.
    Drinka PJ; Nickel DA; Schomisch GW; Depka CH; Deterville RJ
    DICP; 1990 Apr; 24(4):381-2. PubMed ID: 2327116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioavailability studies with Digoxin-Sandoz and Lanoxin.
    Beveridge T; Kalberer F; Nüesch E; Schmidt R
    Eur J Clin Pharmacol; 1975 Jun; 8(5):371-6. PubMed ID: 1243983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Digoxin bioavailability: formulations and rates of infusions.
    Marcus FI; Dickerson J; Pippin S; Stafford M; Bressler R
    Clin Pharmacol Ther; 1976 Sep; 20(3):253-9. PubMed ID: 954346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the bioavailability of digoxin in capsule, tablet, and solution taken orally with intravenous digoxin.
    Binnion PF
    J Clin Pharmacol; 1976 Oct; 16(10 Pt 1):461-7. PubMed ID: 977789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of magnesium--aluminum hydroxide and kaolin--pectin on absorption of digoxin from tablets and capsules.
    Allen MD; Greenblatt DJ; Harmatz JS; Smith TW
    J Clin Pharmacol; 1981 Jan; 21(1):26-30. PubMed ID: 7012189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability of digoxin capsules and tablets: effect of coadministered fluid volume.
    Bustrack JA; Katz JD; Hull JH; Foster JR; Hammond JE; Christenson RH
    J Pharm Sci; 1984 Oct; 73(10):1397-400. PubMed ID: 6502488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An improvement in digoxin bioavailability. Studies with soft gelatin capsules containing a solution of digoxin.
    Alvisi V; Longhini C; Bagni B; Portaluppi F; Ruina M; Fersini C
    Arzneimittelforschung; 1979; 29(7):1047-50. PubMed ID: 582997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and related heart function index of digoxin capsules and tablets in cardiac patients.
    Astorri E; Bianchi G; La Canna G; Assanelli D; Visioli O; Marzo A
    J Pharm Sci; 1979 Jan; 68(1):104-6. PubMed ID: 364006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variability of steady-state digoxin kinetics during administration of tablets or capsules.
    Johnson BF; Lindenbaum J; Budnitz E; Marwaha R
    Clin Pharmacol Ther; 1986 Mar; 39(3):306-12. PubMed ID: 3948469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maximal bioavailability of digoxin from tablets and oral solution in steady state.
    Manninen V; Reissell P; Ojala K
    Acta Med Scand; 1976; 199(6):487-9. PubMed ID: 937075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.